Infective Endocarditis in Belgium: Prospective Data in Adults from the ESC EORP European Endocarditis Registry.
Belgium
cardiac surgery
infective endocarditis
registry
valve disease
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
28 Feb 2024
28 Feb 2024
Historique:
received:
15
01
2024
revised:
04
02
2024
accepted:
26
02
2024
medline:
9
4
2024
pubmed:
9
4
2024
entrez:
9
4
2024
Statut:
epublish
Résumé
(1) Background: infective endocarditis (IE) is a significant health concern associated with important morbidity and mortality. Only limited, often monocentric, retrospective data on IE in Belgium are available. This prospective study sought to assess the clinical characteristics and outcomes of Belgian IE patients in the ESC EORP European endocarditis (EURO-ENDO) registry; (2) Methods: 132 IE patients were identified based on the ESC 2015 criteria and included in six tertiary hospitals in Belgium; (3) Results: The average Belgian IE patient was male and 62.8 ± 14.9 years old. The native valve was most affected (56.8%), but prosthetic/repaired valves (34.1%) and intracardiac device-related (5.3%) IE are increasing. The most frequently identified microorganisms were
Identifiants
pubmed: 38592201
pii: jcm13051371
doi: 10.3390/jcm13051371
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Abbott vascular Int
ID : 2011-2021
Organisme : Amgen Cardiovascular
ID : 2009-2018
Organisme : AstraZeneca
ID : 2014-2021
Organisme : Bayer AG
ID : 2009-2018
Organisme : Boehringer Ingelheim
ID : 2009-2019
Organisme : Boston Scientific
ID : 2009-2012
Organisme : The Bristol Myers Squibb and Pfizer Alliance
ID : 2011-2019
Organisme : Daiichi Sankyo Europe GmbH
ID : 2011-2020
Organisme : The Alliance Daiichi Sankyo Europe GmbH and Eli Lilly and Company
ID : 2014-2017
Organisme : Edwards
ID : 2016-2019
Organisme : Gedeon Richter Plc.
ID : 2014-2016
Organisme : Menarini Int. Op.
ID : 2009-2012
Organisme : MSD-Merck & Co.
ID : 2011-2014
Organisme : Novartis Pharma AG
ID : 2014-2020
Organisme : ResMed
ID : 2014-2016
Organisme : Sanofi
ID : 2009-2011
Organisme : SERVIER
ID : 2009-2021
Organisme : Vifor
ID : 2019-2022